Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1346 |
Name of the vaccine | GSK513026 |
Microbe | Bacteria |
Disease name | Pneumococcal |
Name of bacteria | Streptococcus pneumoniae |
Type of vaccine | NA |
Nucleic acid content | DNA |
Age | 65 years and older |
Description of the vaccine | Pneumococcal protein vaccine. |
Name of the manufacturer | GlaxoSmithKline |
Name of the manufacturing country | Belgium |
Year of manufacture | 2005 |
Clinical Phase status | Clinical - Phase 2 |
Bacterial strain | Gram-positive, facultative anaerobic bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Two doses. |
Mechanism of action | NA |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | With or without adjuvant |
Repurposing | For Invasive Pneumococcal diseases and Pneumonia |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | NA |
Clinical trial number | NCT00307528 |
Reference | NA |
Other name | NA |
Additional Links | NA |